SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Mining the human phenome using allelic scores that index biological intermediates.

Evans, DM; Brion, MJA; Paternoster, L; Kemp, JP; McMahon, G; Munafò, M; Whitfield, JB; Medland, SE; Montgomery, GW; GIANT Consortium, ; et al. Evans, DM; Brion, MJA; Paternoster, L; Kemp, JP; McMahon, G; Munafò, M; Whitfield, JB; Medland, SE; Montgomery, GW; GIANT Consortium; CRP Consortium; TAG Consortium; Timpson, NJ; St Pourcain, B; Lawlor, DA; Martin, NG; Dehghan, A; Hirschhorn, J; Smith, GD (2013) Mining the human phenome using allelic scores that index biological intermediates. PLoS Genet, 9 (10). e1003919. ISSN 1553-7404 https://doi.org/10.1371/journal.pgen.1003919
SGUL Authors: Jamshidi, Yalda

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (688kB) | Preview
[img]
Preview
PDF (Figure S1) Published Version
Download (27kB) | Preview
[img]
Preview
PDF (Figure S2) Published Version
Download (27kB) | Preview
[img]
Preview
PDF (Figure S3) Published Version
Download (27kB) | Preview
[img]
Preview
PDF (Figure S4) Published Version
Download (28kB) | Preview
[img]
Preview
PDF (Figure S5) Published Version
Download (28kB) | Preview
[img]
Preview
PDF (Figure S6) Published Version
Download (28kB) | Preview
[img]
Preview
PDF (File S1) Published Version
Download (258kB) | Preview
[img]
Preview
PDF (File S2) Published Version
Download (153kB) | Preview
[img]
Preview
PDF (File S3) Published Version
Download (143kB) | Preview
[img]
Preview
PDF (Table S1) Published Version
Download (430kB) | Preview
[img]
Preview
PDF (Table S2) Published Version
Download (428kB) | Preview
[img]
Preview
PDF (Table S3) Published Version
Download (425kB) | Preview
[img]
Preview
PDF (Table S4) Published Version
Download (274kB) | Preview
[img]
Preview
PDF (Table S5) Published Version
Download (274kB) | Preview
[img]
Preview
PDF (Table S6) Published Version
Download (274kB) | Preview
[img]
Preview
PDF (Table S7) Published Version
Download (124kB) | Preview
[img]
Preview
PDF (Table S8) Published Version
Download (125kB) | Preview
[img]
Preview
PDF (Table S9) Published Version
Download (101kB) | Preview

Abstract

It is common practice in genome-wide association studies (GWAS) to focus on the relationship between disease risk and genetic variants one marker at a time. When relevant genes are identified it is often possible to implicate biological intermediates and pathways likely to be involved in disease aetiology. However, single genetic variants typically explain small amounts of disease risk. Our idea is to construct allelic scores that explain greater proportions of the variance in biological intermediates, and subsequently use these scores to data mine GWAS. To investigate the approach's properties, we indexed three biological intermediates where the results of large GWAS meta-analyses were available: body mass index, C-reactive protein and low density lipoprotein levels. We generated allelic scores in the Avon Longitudinal Study of Parents and Children, and in publicly available data from the first Wellcome Trust Case Control Consortium. We compared the explanatory ability of allelic scores in terms of their capacity to proxy for the intermediate of interest, and the extent to which they associated with disease. We found that allelic scores derived from known variants and allelic scores derived from hundreds of thousands of genetic markers explained significant portions of the variance in biological intermediates of interest, and many of these scores showed expected correlations with disease. Genome-wide allelic scores however tended to lack specificity suggesting that they should be used with caution and perhaps only to proxy biological intermediates for which there are no known individual variants. Power calculations confirm the feasibility of extending our strategy to the analysis of tens of thousands of molecular phenotypes in large genome-wide meta-analyses. We conclude that our method represents a simple way in which potentially tens of thousands of molecular phenotypes could be screened for causal relationships with disease without having to expensively measure these variables in individual disease collections.

Item Type: Article
Additional Information: © 2013 Evans et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords: Adaptor Proteins, Vesicular Transport, Alleles, C-Reactive Protein, Genetic Diseases, Inborn, Genetic Predisposition to Disease, Genome, Human, Genome-Wide Association Study, Genotype, Humans, Longitudinal Studies, Phenotype, Polymorphism, Single Nucleotide, GIANT Consortium, CRP Consortium, TAG Consortium, Humans, Genetic Diseases, Inborn, Genetic Predisposition to Disease, C-Reactive Protein, Adaptor Proteins, Vesicular Transport, Longitudinal Studies, Genotype, Phenotype, Polymorphism, Single Nucleotide, Alleles, Genome, Human, Genome-Wide Association Study, 0604 Genetics, Developmental Biology
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: PLoS Genet
ISSN: 1553-7404
Language: eng
Dates:
DateEvent
31 October 2013Published
12 September 2013Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
DA019951NIDA NIH HHSUNSPECIFIED
R01 AA007535NIAAA NIH HHSUNSPECIFIED
AA13320NIAAA NIH HHSUNSPECIFIED
R01 AA007728NIAAA NIH HHSUNSPECIFIED
092731Wellcome Trusthttp://dx.doi.org/10.13039/100004440
AA13321NIAAA NIH HHSUNSPECIFIED
AA17688NIAAA NIH HHSUNSPECIFIED
MC_UU_12013/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
UNSPECIFIEDWellcome TrustUNSPECIFIED
R37 AA007728NIAAA NIH HHSUNSPECIFIED
AA07535NIAAA NIH HHSUNSPECIFIED
MC_UU_12013/5Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
AA13326NIAAA NIH HHSUNSPECIFIED
R01 AA014041NIAAA NIH HHSUNSPECIFIED
K05 AA017688NIAAA NIH HHSUNSPECIFIED
MC_UU_12013/3Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
G1000758Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
P50 AA011998NIAAA NIH HHSUNSPECIFIED
R01 AA013326NIAAA NIH HHSUNSPECIFIED
MR/J012165/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
R56 DA012854NIDA NIH HHSUNSPECIFIED
DA012854NIDA NIH HHSUNSPECIFIED
R01 AA013321NIAAA NIH HHSUNSPECIFIED
085515Wellcome Trusthttp://dx.doi.org/10.13039/100004440
AA07728NIAAA NIH HHSUNSPECIFIED
090532Wellcome Trusthttp://dx.doi.org/10.13039/100004440
AA11998NIAAA NIH HHSUNSPECIFIED
MC_UU_12013/4Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
076467Wellcome Trusthttp://dx.doi.org/10.13039/100004440
R01 DA012854NIDA NIH HHSUNSPECIFIED
095515Wellcome Trusthttp://dx.doi.org/10.13039/100004440
G0600717Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
K08 DA019951NIDA NIH HHSUNSPECIFIED
AA14041NIAAA NIH HHSUNSPECIFIED
083431MAWellcome Trusthttp://dx.doi.org/10.13039/100004440
G9815508Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
R01 AA013320NIAAA NIH HHSUNSPECIFIED
74882Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
916.12.154Dutch Research CouncilUNSPECIFIED
241944National Health and Medical Research Councilhttp://dx.doi.org/10.13039/501100000925
339462National Health and Medical Research Councilhttp://dx.doi.org/10.13039/501100000925
389927National Health and Medical Research Councilhttp://dx.doi.org/10.13039/501100000925
389875National Health and Medical Research Councilhttp://dx.doi.org/10.13039/501100000925
389891National Health and Medical Research Councilhttp://dx.doi.org/10.13039/501100000925
389892National Health and Medical Research Councilhttp://dx.doi.org/10.13039/501100000925
389938National Health and Medical Research Councilhttp://dx.doi.org/10.13039/501100000925
442915National Health and Medical Research Councilhttp://dx.doi.org/10.13039/501100000925
442981National Health and Medical Research Councilhttp://dx.doi.org/10.13039/501100000925
496739National Health and Medical Research Councilhttp://dx.doi.org/10.13039/501100000925
552485National Health and Medical Research Councilhttp://dx.doi.org/10.13039/501100000925
552498National Health and Medical Research Councilhttp://dx.doi.org/10.13039/501100000925
A7960034Australian Research Councilhttp://dx.doi.org/10.13039/501100000923
A79906588Australian Research Councilhttp://dx.doi.org/10.13039/501100000923
A79801419Australian Research Councilhttp://dx.doi.org/10.13039/501100000923
DP0770096Australian Research Councilhttp://dx.doi.org/10.13039/501100000923
DP0212016Australian Research Councilhttp://dx.doi.org/10.13039/501100000923
DP0343921Australian Research Councilhttp://dx.doi.org/10.13039/501100000923
247642Seventh Framework Programmehttp://dx.doi.org/10.13039/501100004963
PubMed ID: 24204319
Web of Science ID: WOS:000330367200079
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/112985
Publisher's version: https://doi.org/10.1371/journal.pgen.1003919

Actions (login required)

Edit Item Edit Item